Sezary T-cell activating factor is a Chlamydia pneumoniae-associated protein

J. Todd Abrams, Eric C. Vonderheid, Sonya Kolbe, Denah M. Appelt, E. James Arking, Brian J. Balin

Research output: Contribution to journalArticle

Abstract

We previously identified a protein that was stimulatory for malignant Sezary T cells, termed Sezary T-cell activating factor (SAF). However, the identity of this protein has not been fully elucidated, nor has it's role been determined in the pathogenesis of cutaneous T-cell lymphoma (CTCL). The basis for epidermotropism and proliferation of malignant cells in the skin of patients with CTCL is unknown. Using a monoclonal antibody inhibitory for SAF activity, we demonstrated that SAF is present in the skin of 16 of 27 samples from patients with mycosis fungoides, the predominant form of CTCL. In this report, the SAF determinant is demonstrated to be associated with Chlamydia pneumoniae bacteria by immunohistochemistry, immunoelectron microscopy, and culture analysis. Reactivity of antibodies against an outer membrane protein of C. pneumoniae or against the lipopolysaccharide of Chlamydiae spp. demonstrated that these determinants are coexpressed in 90% of the SAF- positive samples. We confirmed the presence of C. pneumoniae DNA and RNA in the skin by PCR and reverse transcription-PCR and by sequence analysis of the PCR products. The expression of the C. pneumoniae antigens and SAF appears to be associated with active disease in that C. pneumoniae antigens were absent or greatly diminished in the skin of three patients examined after Psoralen and long-wave UVA radiation treatment. Our results suggest that SAF is a Chlamydia-associated protein and that further investigation is warranted to determine whether SAF and C. pneumoniae play a role in the pathogenesis of CTCL.

Original languageEnglish (US)
Pages (from-to)895-905
Number of pages11
JournalClinical and Diagnostic Laboratory Immunology
Volume6
Issue number6
StatePublished - Nov 1999
Externally publishedYes

Fingerprint

TCF Transcription Factors
Chlamydophila pneumoniae
T-cells
Cutaneous T-Cell Lymphoma
Skin
Proteins
Chlamydia
Polymerase Chain Reaction
Ficusin
Antigens
Mycosis Fungoides
Immunoelectron Microscopy
Syntex adjuvant formulation
Transcription
Reverse Transcription
Sequence Analysis
Lipopolysaccharides
Pneumonia
Bacteria
Microscopic examination

ASJC Scopus subject areas

  • Microbiology (medical)
  • Immunology and Allergy
  • Clinical Biochemistry
  • Immunology

Cite this

Abrams, J. T., Vonderheid, E. C., Kolbe, S., Appelt, D. M., Arking, E. J., & Balin, B. J. (1999). Sezary T-cell activating factor is a Chlamydia pneumoniae-associated protein. Clinical and Diagnostic Laboratory Immunology, 6(6), 895-905.

Sezary T-cell activating factor is a Chlamydia pneumoniae-associated protein. / Abrams, J. Todd; Vonderheid, Eric C.; Kolbe, Sonya; Appelt, Denah M.; Arking, E. James; Balin, Brian J.

In: Clinical and Diagnostic Laboratory Immunology, Vol. 6, No. 6, 11.1999, p. 895-905.

Research output: Contribution to journalArticle

Abrams, JT, Vonderheid, EC, Kolbe, S, Appelt, DM, Arking, EJ & Balin, BJ 1999, 'Sezary T-cell activating factor is a Chlamydia pneumoniae-associated protein', Clinical and Diagnostic Laboratory Immunology, vol. 6, no. 6, pp. 895-905.
Abrams JT, Vonderheid EC, Kolbe S, Appelt DM, Arking EJ, Balin BJ. Sezary T-cell activating factor is a Chlamydia pneumoniae-associated protein. Clinical and Diagnostic Laboratory Immunology. 1999 Nov;6(6):895-905.
Abrams, J. Todd ; Vonderheid, Eric C. ; Kolbe, Sonya ; Appelt, Denah M. ; Arking, E. James ; Balin, Brian J. / Sezary T-cell activating factor is a Chlamydia pneumoniae-associated protein. In: Clinical and Diagnostic Laboratory Immunology. 1999 ; Vol. 6, No. 6. pp. 895-905.
@article{be463f6c121442c29001e5b2992eb832,
title = "Sezary T-cell activating factor is a Chlamydia pneumoniae-associated protein",
abstract = "We previously identified a protein that was stimulatory for malignant Sezary T cells, termed Sezary T-cell activating factor (SAF). However, the identity of this protein has not been fully elucidated, nor has it's role been determined in the pathogenesis of cutaneous T-cell lymphoma (CTCL). The basis for epidermotropism and proliferation of malignant cells in the skin of patients with CTCL is unknown. Using a monoclonal antibody inhibitory for SAF activity, we demonstrated that SAF is present in the skin of 16 of 27 samples from patients with mycosis fungoides, the predominant form of CTCL. In this report, the SAF determinant is demonstrated to be associated with Chlamydia pneumoniae bacteria by immunohistochemistry, immunoelectron microscopy, and culture analysis. Reactivity of antibodies against an outer membrane protein of C. pneumoniae or against the lipopolysaccharide of Chlamydiae spp. demonstrated that these determinants are coexpressed in 90{\%} of the SAF- positive samples. We confirmed the presence of C. pneumoniae DNA and RNA in the skin by PCR and reverse transcription-PCR and by sequence analysis of the PCR products. The expression of the C. pneumoniae antigens and SAF appears to be associated with active disease in that C. pneumoniae antigens were absent or greatly diminished in the skin of three patients examined after Psoralen and long-wave UVA radiation treatment. Our results suggest that SAF is a Chlamydia-associated protein and that further investigation is warranted to determine whether SAF and C. pneumoniae play a role in the pathogenesis of CTCL.",
author = "Abrams, {J. Todd} and Vonderheid, {Eric C.} and Sonya Kolbe and Appelt, {Denah M.} and Arking, {E. James} and Balin, {Brian J.}",
year = "1999",
month = "11",
language = "English (US)",
volume = "6",
pages = "895--905",
journal = "Clinical and Vaccine Immunology",
issn = "1556-6811",
publisher = "American Society for Microbiology",
number = "6",

}

TY - JOUR

T1 - Sezary T-cell activating factor is a Chlamydia pneumoniae-associated protein

AU - Abrams, J. Todd

AU - Vonderheid, Eric C.

AU - Kolbe, Sonya

AU - Appelt, Denah M.

AU - Arking, E. James

AU - Balin, Brian J.

PY - 1999/11

Y1 - 1999/11

N2 - We previously identified a protein that was stimulatory for malignant Sezary T cells, termed Sezary T-cell activating factor (SAF). However, the identity of this protein has not been fully elucidated, nor has it's role been determined in the pathogenesis of cutaneous T-cell lymphoma (CTCL). The basis for epidermotropism and proliferation of malignant cells in the skin of patients with CTCL is unknown. Using a monoclonal antibody inhibitory for SAF activity, we demonstrated that SAF is present in the skin of 16 of 27 samples from patients with mycosis fungoides, the predominant form of CTCL. In this report, the SAF determinant is demonstrated to be associated with Chlamydia pneumoniae bacteria by immunohistochemistry, immunoelectron microscopy, and culture analysis. Reactivity of antibodies against an outer membrane protein of C. pneumoniae or against the lipopolysaccharide of Chlamydiae spp. demonstrated that these determinants are coexpressed in 90% of the SAF- positive samples. We confirmed the presence of C. pneumoniae DNA and RNA in the skin by PCR and reverse transcription-PCR and by sequence analysis of the PCR products. The expression of the C. pneumoniae antigens and SAF appears to be associated with active disease in that C. pneumoniae antigens were absent or greatly diminished in the skin of three patients examined after Psoralen and long-wave UVA radiation treatment. Our results suggest that SAF is a Chlamydia-associated protein and that further investigation is warranted to determine whether SAF and C. pneumoniae play a role in the pathogenesis of CTCL.

AB - We previously identified a protein that was stimulatory for malignant Sezary T cells, termed Sezary T-cell activating factor (SAF). However, the identity of this protein has not been fully elucidated, nor has it's role been determined in the pathogenesis of cutaneous T-cell lymphoma (CTCL). The basis for epidermotropism and proliferation of malignant cells in the skin of patients with CTCL is unknown. Using a monoclonal antibody inhibitory for SAF activity, we demonstrated that SAF is present in the skin of 16 of 27 samples from patients with mycosis fungoides, the predominant form of CTCL. In this report, the SAF determinant is demonstrated to be associated with Chlamydia pneumoniae bacteria by immunohistochemistry, immunoelectron microscopy, and culture analysis. Reactivity of antibodies against an outer membrane protein of C. pneumoniae or against the lipopolysaccharide of Chlamydiae spp. demonstrated that these determinants are coexpressed in 90% of the SAF- positive samples. We confirmed the presence of C. pneumoniae DNA and RNA in the skin by PCR and reverse transcription-PCR and by sequence analysis of the PCR products. The expression of the C. pneumoniae antigens and SAF appears to be associated with active disease in that C. pneumoniae antigens were absent or greatly diminished in the skin of three patients examined after Psoralen and long-wave UVA radiation treatment. Our results suggest that SAF is a Chlamydia-associated protein and that further investigation is warranted to determine whether SAF and C. pneumoniae play a role in the pathogenesis of CTCL.

UR - http://www.scopus.com/inward/record.url?scp=0032585968&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032585968&partnerID=8YFLogxK

M3 - Article

C2 - 10548583

AN - SCOPUS:0032585968

VL - 6

SP - 895

EP - 905

JO - Clinical and Vaccine Immunology

JF - Clinical and Vaccine Immunology

SN - 1556-6811

IS - 6

ER -